Company Overview and News

 
Recent Purchase: Texas Instruments

2018-10-11 seekingalpha
I used the tech sell-off over the last week or so to initiate exposure of beaten down Texas Instruments.
TXN

8
My Top 10 Technology Stocks For Dividend Growth Investors

2018-10-11 seekingalpha - 1
With interest rates on the rise during the past week or so, the technology sector has experienced a rather severe short-term sell-off. It appears that the Federal Reserve is causing the market to begin to shift to risk-off mode. Granted, this could all be short-lived if Jerome Powell & Co. would simply mention that they’re planning on being data dependent, so I’m not sure if it’s time for investors to get all up in arms.
TXN AAPL AVGO MSFT NVDA INTC

2
For Retirees, A Most Compelling Case For Dividend Growth And Modest Dividend Income

2018-10-09 seekingalpha
We'll look at an example where we'll take the dividend yield and then top that up with share harvesting to create that 4%+ income value.
BLK TXN AAPL DVY MSFT

1
Raymond James slashes chip stock profit estimates, says it is 'too early' to call bottom on sector

2018-10-08 cnbc
The firm reduced its 2019 earnings estimates for eight chip stocks, predicting companies will announce weakness in business activity.
TXN ADI

48
My Dividend Growth Portfolio - Q3 2018 Summary

2018-10-07 seekingalpha
I believe that someone who writes about financial assets should share his main holdings with his readers.
FB GIS RDS.B TXN TWX O GOOG OPRF TWC NKE KHC SBUX MSFT ADM OHI MCD

38
The Ratings Game: Chip stocks hit worst as tech selloff drags broader market lower

2018-10-05 marketwatch - 2
Chip-related stocks fell Friday as the subsector got hit the hardest in a tech-stocks selloff, significantly widening its underperformance to the broader market for the year.
MRVL QRVO CY TXN CRUS AMD NVDA SWKS AAPL AVGO ADI BRCM INTC MXIM

5
Dip in Semiconductor Stocks Temporary: 4 Picks

2018-10-05 zacks
On Oct 4, chip stocks took a beating after Deutsche Bank (DB - Free Report) reduced its 2019 earnings estimates for a number of chipmakers, citing growing weakness in business activity. This raised panic among investors, leading to huge selloffs on Thursday.
XLNX PLAB DB TXN ASML ADI VSH MXIM YY

63
Q3 Portfolio Review

2018-10-05 seekingalpha - 1
This is the third quarter review of my retirement income portfolio. It was a very active quarter that included a final pension rollover to my IRA. About half of the rollover funds have been deployed. Some existing positions were trimmed to take profit and to diversify. In recent weeks, I've written articles about the 19 new positions, so this review will be a brief summary.
TXN CNUTF XOM RDSB ENB OPRF RDSA FTS WMT BCE CSCO ABBV DUKH BAMGF SO UPS MAIN TYT KMB CMI ENB MFC RY 0945 BNS JNJ ITW RYDBF 7203 WPC SPG ABBV MSFT QCOM PFE CLX CDUAF BAMKF NNN SOJA TM ADP SKT EPD TD ETN BNS MSCA AAPL BIP RYDAF TD CSCOI BAM BEP CU VTR IBM RDS.B RY RDS.A TNTTF APLE O DUK FDX TOYOF MSCA.CL BLK HP PEP ADPVV FTS PPL MFC

1
Chip stocks drop after analyst cuts industry earnings estimates due to big 'downturn' risk

2018-10-04 cnbc
The firm reduced its 2019 earnings estimates by 5 percent on average for eight chip stocks, citing increasing weakness in business activity.
TXN ADI MS

6
Texas Instruments Boosts Industrial Share With New Amplifier

2018-10-04 zacks
Texas Instruments Incorporated (TXN - Free Report) or TI recently took the wraps off an isolated amplifier, which it claims to deliver accurate signal measurements in industrial voltage-sensing applications.
TXN CSBR EXPI ADI INAP

30
AMD: Why The Share Price Increased 200% This Year

2018-10-03 seekingalpha - 4
AMD has had an amazing price run of almost 200% this year, becoming the top performing share in the S&P 500 index for 2018.
IBM TXN AMD NVDA INTC FSL HPE

4
Trimming Qualcomm To Initiate A Position In NXP Semiconductors

2018-10-03 seekingalpha
NXPI has a strong and sustainable industry positioning, attractive cash returns on invested capital and a solid financial base to continue growing.
TXN QCOM

 
Serial System says unit to lose distribution deal with Texas Instruments; may sell that business

2018-10-03 businesstimes.com.sg
A WHOLLY owned subsidiary of mainboard-listed Serial System, Serial Microelectronics, will have its distribution agreement with major supplier Texas Instruments (TI) terminated on Dec 31, 2018, Serial System announced late on Tuesday.
TXN S69

 
Serial System announces S$0.01 special dividend after selling laundry business

2018-10-03 businesstimes.com.sg
ELECTRONIC components distributor Serial System has proposed to distribute a special dividend of one Singapore cent per share, following the disposal of its Australian laundry business.
TXN S69

 
Stocks to watch: Aspial, Serial System, Sembcorp, Stamford Land

2018-10-03 businesstimes.com.sg
Aspial: Aspial Corp is launching S$20.75 million in additional notes under its S$700 million multi-currency debt issuance programme at a coupon of 6.25 per cent following interest from its investors. The notes, which are due 2021, add to an earlier tranche of S$29.25 million in notes, taking the total under the Series 006 notes that will be issued to S$50 million. The Series 006 notes are expected to be issued on Oct 11, and will be used to finance the general funding requirements or investments of the group, for working capital and for capital expenditure.
TXN MLYBY MLYNF U96 HYFXY S69 SCRPY 1155 M35 H07 HYFXF SCRPF SMFOY

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to TXN / Texas Instruments Inc. on message board site Silicon Investor.

Texas Instruments - Good buy now or should we wait? Texas Instruments - Good buy now or should we wait? Texas Instruments - Good buy now or should we wait? Stratex Networks, Inc. (STXN) Stratex Networks, Inc. (STXN) Stratex Networks, Inc. (STXN)
STXN: DMC Stratex Networks Inc. STXN: DMC Stratex Networks Inc. STXN: DMC Stratex Networks Inc. NOK EDMC TXN ALTR MU NOK EDMC TXN ALTR MU NOK EDMC TXN ALTR MU
Possible Hot Tech Plays (TXN, QWST, AMCC, etc...) Possible Hot Tech Plays (TXN, QWST, AMCC, etc...) Possible Hot Tech Plays (TXN, QWST, AMCC, etc...) A Discussion re. Memory: MU CY TXN ALSC IDTI ISSI etc. A Discussion re. Memory: MU CY TXN ALSC IDTI ISSI etc. A Discussion re. Memory: MU CY TXN ALSC IDTI ISSI etc.
Texas Instruments (TXN) Texas Instruments (TXN) Texas Instruments (TXN) INTC, TXN, AMD or CRUS - WHAT should I buy? INTC, TXN, AMD or CRUS - WHAT should I buy? INTC, TXN, AMD or CRUS - WHAT should I buy?
CUSIP: 882508104